|
|
||||||||||
|
J Am Coll Cardiol, 2005; 46:994-1001, doi:10.1016/j.jacc.2005.02.094 © 2005 by the American College of Cardiology Foundation |
,
,*



* Research Group for Arteriogenesis, Department of Cardiology, University of Freiburg, Freiburg, Germany
Perfusion Technologies GmbH, Freiburg, Germany
Department of Experimental Cardiology, UMC, University of Utrecht, Utrecht, the Netherlands
Department of Cardiology, AMC, University of Amsterdam, Amsterdam, the Netherlands
|| Humboldt University, Center for Cardiovascular Research, Charité, Berlin, Germany.
Manuscript received August 4, 2004; revised manuscript received January 20, 2005, accepted February 14, 2005.
* Reprint requests and correspondence: Dr. Imo E. Hoefer, UMC Utrecht, G02.523, Heidelberglaan 100, NL-3584 CX Utrecht, the Netherlands. (Email: i.hoefer{at}azu.nl).
OBJECTIVES: The objective of this study was to test the potential of aspirin and clopidogrel to influence collateral artery growth (arteriogenesis).
BACKGROUND: Aspirin and clopidogrel are antiplatelet agents commonly used in the treatment of ischemic cardiovascular disease. Both inhibit platelet aggregation; however, they differ mechanistically because aspirin acts via cyclooxygenase (COX) inhibition, while clopidogrel noncompetitively antagonizes the P2Y12 adenosine diphosphate receptor. We hypothesized that aspirin, due to its anti-inflammatory effects through inhibition of COX activity could inhibit arteriogenesis. Given that clopidogrel does not affect COX activity, it would be less likely to interfere with collateral artery growth.
METHODS: Fifty-four New Zealand White rabbits received either saline, aspirin (10 mg/kg), or clopidogrel (10 mg/kg) for seven days after femoral artery ligation. Maximal collateral conductance was assessed with fluorescent microspheres under maximal vasodilation; cellular migration and proliferation (Ki-67) was evaluated by quantitative immunohistology.
RESULTS: Collateral conductance was significantly reduced by aspirin treatment, whereas clopidogrel had a neutral effect (saline: 0.94 ± 0.04; clopidogrel: 0.94 ± 0.05; aspirin: 0.64 ± 0.03 ml·min1·100 mm Hg1·g1; p < 0.001). Ki-67 proliferation indexes were consistent with these results (saline: 23.1 ± 2.9%; clopidogrel: 23.5 ± 1.1%; aspirin: 19.2 ± 1.1% Ki-67positive cells). Immunohistochemistry showed COX expression in collateral arteries and a significantly decreased monocyte/macrophage accumulation in the perivascular tissue after aspirin treatment. Cell adhesion molecule expression on monocytes after activation was significantly reduced by aspirin, which might explain the reduced migratory ability.
CONCLUSIONS: In summary, clopidogrel had a neutral effect on natural arteriogenesis. Aspirin significantly inhibited collateral artery growth, probably due to its anti-inflammatory effect. Additional studies are needed to substantiate these results before translation into clinical practice.
| |||||||||
This article has been cited by other articles:
![]() |
P. Rousseau, M. Tartas, B. Fromy, A. Godon, M.-A. Custaud, J. L. Saumet, and P. Abraham Platelet inhibition by low-dose aspirin but not by clopidogrel reduces the axon-reflex current-induced vasodilation in humans Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1420 - R1426. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Grundmann, N. van Royen, G. Pasterkamp, N. Gonzalez, E. J. Tijsma, J. J. Piek, and I. E. Hoefer A New Intra-Arterial DeliveryPlatform for Pro-Arteriogenic Compounds to Stimulate Collateral Artery Growth Via Transforming Growth Factor-{beta}1 Release J. Am. Coll. Cardiol., July 24, 2007; 50(4): 351 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Birnbaum, Y. Lin, Y. Ye, J. D. Martinez, M.-H. Huang, C. Y. Lui, J. R Perez-Polo, and B. F. Uretsky Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2891 - H2897. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |